Skip to main content

Table 1 Baseline characteristics of study participants

From: Correlation between short- and mid-term hemoglobin A1c and glycemic control determined by continuous glucose monitoring

 

All (n = 82)

Type 1 DM (n = 23)

Type 2 DM (n = 59)

Age (year)

59.7 ± 16.2

46.2 ± 17.1*

64.9 ± 12.4

Sex (% women)

44 (54)

11 (48)

33 (56)

Body weight (kg)

65.5 ± 12.3

66.6 ± 15.1

65.1 ± 11.1

Body height (m)

1.62 ± 0.09

1.65 ± 0.07*

1.60 ± 0.09

BMI (kg/m2)

25 ± 4

24 ± 4

25 ± 3

Duration of DM (year)

15.3 ± 8.8

15.3 ± 10.3

15.3 ± 8.3

Mean glucose level (mg/dL)

156.6 ± 36.6

152.2 ± 27.1

158.3 ± 40.1

Complication of DM

   

 Retinopathy (%)

23 (28%)

4 (17%)

19 (32%)

 Nephropathy (%)

22 (27%)

4 (17%)

18 (31%)

 Neuropathy (%)

30 (37%)

5 (22%)

25 (42%)

Insulin (%)

71 (87%)

23 (100%)*

48 (81%)

Sulfonylurea (%)

8 (10%)

0 (0%)

8 (14%)

Glinides (%)

2 (2%)

0 (0%)

2 (3%)

Metformin (%)

37 (45%)

1 (4%)*

36 (61%)

α-Glucosidase inhibitor (%)

11 (13%)

0 (0%)*

11 (19%)

Thiazolidinedione (%)

4 (5%)

0 (0%)

4 (7%)

DPP-4 inhibitor (%)

23 (28%)

0 (0%)*

23 (39%)

SGLT2i (%)

6 (7%)

0 (0%)

6 (10%)

GLP-1 RA (%)

1 (1%)

0 (0%)

1 (2%)

Change of treatment

   

 Increase insulin dose (%)

40 (49%)

14 (61%)

26 (44%)

 Decrease insulin dose (%)

17 (21%)

4 (17%)

13 (22%)

 Increase oral antidiabetic agent (%)

6 (7%)

0 (0%)

6 (10%)

 Decrease oral antidiabetic agent (%)

4 (5%)

0 (0%)

4 (7%)

SD (mg/dL)

44.3 ± 16.6

55.1 ± 18.1*

39.6 ± 13.6

MAGE (mg/dL)

117.7 ± 34.0

135.4 ± 31.8*

110.2 ± 32.3

CONGA-1 (mg/dL)

29.9 ± 9.1

35.4 ± 8.1*

27.6 ± 8.5

%CV

28.5 ± 9.6

35.2 ± 10.2*

25.6 ± 7.7

  1. DM: diabetes mellitus; BMI: body mass index; HbA1c: hemoglobin A1c; DPP-4: dipeptidyl peptidase 4; SGLT2i: sodium-glucose co-transporter 2 inhibitors; GLP-1 RA: glucagon-like peptide-1 receptor agonist; SD: standard deviation; MAGE: mean amplitude of glucose excursion; CONGA: Continuous overlapping net glycemic action (1 h intervals); %CV: percentage coefficient of variation; Data are mean ± SD
  2. *Means type 1 DM versus type 2 DM; P < 0.05